MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences EV/EBITDA Ratio 2011-2026 | ANIX
Annual EV/EBITDA Ratio Anixa Biosciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.25 | -5.26 | -6.54 | -4.93 | -4.72 | -12.5 | -36.6 | -7.89 | -6.32 | -9.6 | -4.59 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.25 | -36.6 | -9.2 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
27.4 | $ 116.83 | 2.6 % | $ 35.5 B | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 25.13 | 1.19 % | $ 698 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 196.66 | 2.95 % | $ 140 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 18.02 | 1.98 % | $ 960 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
39.5 | $ 65.77 | 4.21 % | $ 25.7 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 16.25 | 2.14 % | $ 491 M | USA |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 15.84 | -1.55 % | $ 170 M |  China |
 |
Guardant Health
GH
|
-28.8 | $ 94.49 | 1.28 % | $ 11.8 B | USA |
 |
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
22 | $ 176.18 | 3.87 % | $ 8.73 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-4.25 | $ 14.28 | -1.72 % | $ 1.85 B | USA |
 |
ICON Public Limited Company
ICLR
|
38 | $ 108.06 | 0.84 % | $ 8.91 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 1.99 | -0.25 % | $ 8.8 M | USA |
 |
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | USA |
 |
Illumina
ILMN
|
70.5 | $ 128.36 | 1.52 % | $ 20.4 B | USA |
 |
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 174.45 | 2.3 % | $ 30 B | USA |
 |
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 275.15 | 2.22 % | $ 22.9 B | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 80.09 | 2.57 % | $ 5.41 B | USA |
 |
Biomerica
BMRA
|
-6.24 | $ 2.16 | - | $ 4.96 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.17 | 0.02 % | $ 6.37 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Medpace Holdings
MEDP
|
30.7 | $ 523.59 | 2.96 % | $ 15.1 B | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 323.64 | 4.22 % | $ 27.3 B | Schweiz |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 4.86 | 2.43 % | $ 450 M | USA |
 |
Celcuity
CELC
|
-2.38 | $ 116.44 | 0.76 % | $ 5.44 B | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 8.3 | 2.98 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
40.3 | $ 10.53 | 5.46 % | $ 2.28 B | USA |
 |
Natera
NTRA
|
-19.5 | $ 211.61 | 1.12 % | $ 20.8 B | USA |
 |
National Research Corporation
NRC
|
21 | $ 17.63 | 3.43 % | $ 395 M | USA |